201 BROOKLINE AVENUE, BOSTON, MA
Reports First Quarter 2026 Financial Results and Provides Business Highlights
CFO Departure - Daniella Beckman Steps Down at Tango Therapeutics
Annual Report to Security Holders
Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
Financial Results, Press Release
The Next Wave of Targeted Therapies in Oncology
Appoints Sung Lee to Board of Directors
Material disclosure
Q1
FY 2025
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
S-3ASR
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Submission Upload